Subsidiary Guarantors - Condensed Consolidating Statement of Cash Flows (Details) (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 27, 2014	Sep. 28, 2013
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	$ (45,384)	$ (14,409)
Investing Activities
Capital expenditures	(8,472)	(8,899)
Supply center acquisition	0	(348)
Proceeds from sale of assets	9	49
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	(8,463)	(9,198)
Financing Activities
Borrowings under ABL facilities	161,931	123,944
Payments under ABL facilities	(116,017)	(200,944)
Borrowings from affiliates	0	0
Repayments to affiliates	0	0
Equity contribution from parent	0	742
Issuance of senior notes	0	106,000
Financing costs	0	(5,445)
Net cash provided by (used in) financing activities	45,914	24,297
Effect of exchange rate changes on cash and cash equivalents	(471)	(80)
Net increase (decrease) in cash and cash equivalents	(8,404)	610
Cash and cash equivalents at beginning of period	20,815	9,594
Cash and cash equivalents at end of period	12,411	10,204
Company
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(54,847)	7,821
Investing Activities
Capital expenditures	7,187	8,496
Supply center acquisition		348
Proceeds from sale of assets	6	49
Payments on loans to affiliates	0	(20,000)
Receipts on loans to affiliates	3,900	5,000
Net cash (used in) provided by investing activities	(3,281)	(23,795)
Financing Activities
Borrowings under ABL facilities	113,700	79,891
Payments under ABL facilities	67,700	148,391
Borrowings from affiliates	12,696	0
Repayments to affiliates	0	(15,074)
Equity contribution from parent		742
Issuance of senior notes		106,000
Financing costs		5,030
Net cash provided by (used in) financing activities	58,696	18,138
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	568	2,164
Cash and cash equivalents at beginning of period	7,566	7,320
Cash and cash equivalents at end of period	8,134	9,484
Co-Issuer
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Supply center acquisition		0
Proceeds from sale of assets	0	0
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	0	0
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Borrowings from affiliates	0	0
Repayments to affiliates	0	0
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Subsidiary Guarantors
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	12,948	(15,064)
Investing Activities
Capital expenditures	252	10
Supply center acquisition		0
Proceeds from sale of assets	0	0
Payments on loans to affiliates	(12,696)	0
Receipts on loans to affiliates	0	15,074
Net cash (used in) provided by investing activities	(12,948)	15,064
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Borrowings from affiliates	0	0
Repayments to affiliates	0	0
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		0
Net cash provided by (used in) financing activities	0	0
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	0	0
Non-Guarantor Subsidiaries
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	(3,485)	(7,166)
Investing Activities
Capital expenditures	1,033	393
Supply center acquisition		0
Proceeds from sale of assets	3	0
Payments on loans to affiliates	0	0
Receipts on loans to affiliates	0	0
Net cash (used in) provided by investing activities	(1,030)	(393)
Financing Activities
Borrowings under ABL facilities	48,231	44,053
Payments under ABL facilities	48,317	52,553
Borrowings from affiliates	0	20,000
Repayments to affiliates	(3,900)	(5,000)
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		415
Net cash provided by (used in) financing activities	(3,986)	6,085
Effect of exchange rate changes on cash and cash equivalents	(471)	(80)
Net increase (decrease) in cash and cash equivalents	(8,972)	(1,554)
Cash and cash equivalents at beginning of period	13,249	2,274
Cash and cash equivalents at end of period	4,277	720
Reclassification/Eliminations
Condensed Financial Statements, Captions [Line Items]
Net cash (used in) provided by operating activities	0	0
Investing Activities
Capital expenditures	0	0
Supply center acquisition		0
Proceeds from sale of assets	0	0
Payments on loans to affiliates	12,696	20,000
Receipts on loans to affiliates	(3,900)	(20,074)
Net cash (used in) provided by investing activities	8,796	(74)
Financing Activities
Borrowings under ABL facilities	0	0
Payments under ABL facilities	0	0
Borrowings from affiliates	(12,696)	(20,000)
Repayments to affiliates	3,900	20,074
Equity contribution from parent		0
Issuance of senior notes		0
Financing costs		0
Net cash provided by (used in) financing activities	(8,796)	74
Effect of exchange rate changes on cash and cash equivalents	0	0
Net increase (decrease) in cash and cash equivalents	0	0
Cash and cash equivalents at beginning of period	0	0
Cash and cash equivalents at end of period	$ 0	$ 0